Filing search / Iovance Biotherapeutics, Inc. / "Department of" / Page 3

8-K

EX-1.1

k7dbpfl g2u

9 Feb 21

Entry into a Material Definitive Agreement

6:01am

8-K

EX-10.1

7emuux

8 Feb 21

Entry into a Material Definitive Agreement

9:55pm

8-K

EX-99.1

gaatkm61

7 Jan 21

Tumor Infiltrating Lymphocyte Cell Therapy for Treatment of Solid Tumors January 2021 © 2021, Iovance Biotherapeutics, Inc 1

6:05am

8-K

EX-99.1

8zrrffnx309adin

5 Oct 20

Investigating the Power of Tumor Infiltrating Lymphocytes for Treatment of Cancer October 2020

5:15pm

8-K

EX-99.1

9itah3pmabsip3z36x0

2 Jun 20

Iovance Biotherapeutics, Inc. Announces Closing of $603.7 Million Common Stock Public Offering

4:56pm

8-K

EX-1.1

94voqc

29 May 20

Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock

4:22pm

8-K

EX-99.1

u3e0i9g7 9bowheqgmh

29 May 20

Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock

4:22pm

8-K

EX-99.2

w5ilq2kxt3o68jqm fj0

29 May 20

Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock

4:22pm

8-K

EX-99.1

779jkg

22 May 20

Investigating the Power of Tumor Infiltrating Lymphocytes for Treatment of Cancer May 2020

4:31pm

8-K

EX-99.1

impmlc

8 May 20

In the United States District Court for the District of Delaware

5:17pm

8-K

EX-99.2

ee2up7v

8 May 20

In the United States District Court for the District of Delaware

5:17pm

8-K

EX-99.1

ebn109wl

2 Jul 19

July 2019 © 2019, Iovance Biotherapeutics, Inc. Investigating the Power of Tumor Infiltrating Lymphocytes for Treatment of Solid Tumors

8:00am